ABH Healthcare IPO

The ABH Healthcare SME IPO is open between 24 Aug 2026 and 27 Aug 2026, offered at a price band of ₹96–102 per share, and is set to list on NSE. The IPO seeks to raise ₹34.98 crore. Retail investors bid in lots of 1200 shares, a minimum application of ₹2,44,800.

Issue structure

The IPO is structured entirely as a fresh issue of ₹33.22 crore, so the full proceeds flow to the company to fund its stated objects of the issue.

Objects of the issue

Per the offer document, the company intends to deploy the net proceeds primarily toward repayment / prepayment, in part or full, of certain of borrowings (₹17 crore), alongside funding working capital requirements (₹5 crore). In all, 3 objects are disclosed — the full break-up is in the table above.

Financials

In FY2026, ABH Healthcare reported revenue of ₹52.59 crore and a net profit of ₹5.64 crore. Revenue grew from ₹41.39 crore in FY2024 to ₹52.59 crore in FY2026 (+27.0%). Net worth stood at ₹17.27 crore at the end of FY2026. At the upper band, that puts the issue at roughly 14.5× FY2026 earnings (P/E), a figure worth comparing against listed peers in the sector.

Valuation

At the upper band, the issue is priced at 20.69× post-issue earnings and 4.73× book value, against a return on net worth of 39.07% and a debt-to-equity ratio of 3.2. These ratios come from the offer document and are for comparison, not a recommendation.

Peer comparison

The offer document names listed peers including Asarfi Hospital Limited and Maitreya Medicare Limited, with a median peer P/E of about 24.5×. The issue's own post-issue P/E works out to 20.69×.

Promoters

The promoters of the company are <p>Kamal Baghi, Saurabh Baghi, Vaishali Saini</p>. Promoter holding stands at 100% before the issue and comes down to 69.99% after listing.

Grey market premium (GMP)

In the unofficial grey market, ABH Healthcare shares are quoted at a premium of ₹0 implying an expected listing around ₹102, about +0.0% over the upper band. Grey market premium is a sentiment indicator set by private dealers, not the company or the exchange — it moves quickly and is not a reliable predictor of the actual listing price.

What to weigh

When evaluating the ABH Healthcare IPO, the data points most investors look at are the fresh-issue-versus-OFS split, the revenue and profitability trend and the grey market premium. Grey market premium and subscription figures reflect short-term sentiment rather than long-term fundamentals; the figures on this page are for information only and are not investment advice.

About ABH Healthcare

ABH Healthcare Ltd provides healthcare services, operates under the name "Anil Baghi Hospital". The company has 150 beds and offer 25 medical specialities, including cardiac sciences, neurology, minimally invasive spine and brain surgeries, medical and surgical gastroenterology, laparoscopic and bariatric surgery, urology, pulmonology, nephrology, ENT, maxillofacial surgeries, etc. The hospital has empaneled with 30 private and public health insurance providers and third-party administrators. We also participate in major government healthcare schemes such as the Ex-Servicemen Contributory Health Scheme (ECHS), Railways, Food Corporation of India (FCI), Bharat Sanchar Nigam Limited (BSNL), and Ayushman Bharat - Sarbat Sehat Bima Yojana (ABSSBY). As of March 31, 2025, it has 29 doctors and 137 nurses. Competitive Strengths Doctor led professional management team with proven execution capabilities Best quality clinical care by attracting and retaining experienced and renowned clinicians Diversified operations across clinical specialties Robust operating infrastructure including information technology and modern equipments Track record of stable operating and financial performance and growth